Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Treatment glial cell line-derived neurotrophic factor

Lapchak PA (1998) A preclinical development strategy designed to optimize the use of glial cell line derived neurotrophic factor in the treatment of Parkinson s disease. Mov Disord 13 Suppl 1 49-54. [Pg.585]

As a quantitatively measurable specific function of glial cells, the rate of synthesis of three neurotrophic factors (nerve growth factor [NGF] brain-derived neurotrophic factor [BDNF] and glial cell line-derived neurotrophic factor [GDNF]) was measured. In the Ohta et al. (2002) study, the enhancer effect of (-)-BPAP was measured only in the high concentration range. The authors found the amount of NGF, BDNF, and GDNF secreted from astrocytes into the culture medium increased by up to 120,2, and 7 times more, respectively, than those of the control treatment with 0.35 mM (-)-BPAP for 24 h. The (-)-BPAP-... [Pg.42]

See other pages where Treatment glial cell line-derived neurotrophic factor is mentioned: [Pg.373]    [Pg.1295]    [Pg.46]    [Pg.203]    [Pg.277]    [Pg.713]    [Pg.192]    [Pg.1322]    [Pg.277]    [Pg.356]    [Pg.357]    [Pg.1]    [Pg.9]    [Pg.768]    [Pg.144]    [Pg.67]    [Pg.285]    [Pg.650]   
See also in sourсe #XX -- [ Pg.642 , Pg.652 ]

See also in sourсe #XX -- [ Pg.642 , Pg.652 ]



SEARCH



Cell factor

Glial

Glial cell

Glial cell line-derived neurotrophic

Glial cell line-derived neurotrophic factor

Neurotrophic

Neurotrophic factors

© 2024 chempedia.info